The SPATA7 gene helps light sensing cells in the retina move key proteins needed for vision. If it does not work properly, these cells can gradually stop working, causing early vision loss, poor night vision, or tunnel vision. The protein made by this gene supports the link between parts of each photoreceptor cell. Pathogenic variants in the SPATA7 gene are linked to inherited retinal conditions including Leber congenital amaurosis and some forms of retinitis pigmentosa.
What is a gene?
A gene is a piece of DNA that gives your cells instructions they can use to make molecules or manage activities in the body. Some genes carry the directions for building proteins, which do much of the cell’s work. Other genes mainly regulate when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
SPATA7Gene function
What if the gene works
The SPATA7 gene helps light-sensing cells in the retina stay organized and move proteins to the right place for vision. This supports normal retinal function and helps these cells keep working over time.
Risk
What if the gene does not work
Variants in the SPATA7 gene can disrupt the retina’s light-sensing cells, causing inherited vision loss such as Leber congenital amaurosis or retinitis pigmentosa. Milder or more severe variants can influence when symptoms start and how much vision is affected.
Treatment
What does that mean for your treatment
No SPATA7-specific treatment or management approach is currently established. The SPATA7 gene is being studied as a target for inherited retinal disease therapies, including gene replacement approaches in preclinical research.
Conditions associated with SPATA7
Gene function
What if the gene works
The clearest job of the SPATA7 gene is in the retina, the light sensing layer at the back of the eye. It helps photoreceptor cells keep their inner and outer parts connected and organized. This support lets these cells move important proteins to the area that captures light.
In rods and cones, the SPATA7 gene helps maintain the narrow bridge between the inner and outer parts of each light sensing cell. This bridge links the area that makes cell parts to the tip that captures light.
Its protein supports the steady movement of key proteins through that bridge to the light detecting tip of the cell. This is a central part of SPATA7 gene function in the retina, where constant delivery helps photoreceptors work normally.
The SPATA7 gene also helps the light detecting tip stay neatly arranged. That orderly structure matters because it holds the stacked membranes that begin the process of vision.
What is a variant?
Genetic variants are small changes in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the SPATA7 gene make the protein too short, unstable, or absent, so retinal cells cannot move and position key proteins normally. This disrupts the light-sensing cells' transport system, especially near the connecting bridge between cell parts. In SPATA7 gene variants in inherited retinal disease, milder changes may leave some protein activity, while more disruptive variants can remove most function. That difference can influence how early vision problems begin and how severe they become.
How variants are linked to conditions
Pathogenic variants in the SPATA7 gene cause inherited retinal conditions, especially Leber congenital amaurosis and early-onset retinitis pigmentosa. In some people, SPATA7 gene changes are also linked to other severe childhood retinal dystrophies. These diagnoses involve the eye’s light-sensing tissue and typically lead to vision loss beginning in infancy or childhood.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most of these variants do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, one well-characterized variant in a particular gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SPATA7, risk is mainly shaped by whether someone is born with disease-causing changes in both copies of the gene, rather than by lifestyle or everyday exposures. There is not broadly confirmed evidence that specific habits or environmental factors clearly increase or lower SPATA7-related risk.
Inheritance of SPATA7 variants
For families asking how SPATA7 variants are inherited, the usual SPATA7 inheritance pattern is autosomal recessive. This means a person typically has to inherit two disease-causing variants in the SPATA7 gene, one from each parent, to have a SPATA7-related eye condition. Parents who each carry one variant are often unaffected carriers. With each pregnancy, two carrier parents have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant.
What does my SPATA7 result mean for my family?
For families with a disease-causing SPATA7 result, relatives are usually affected only when they inherit a changed copy from both parents. Brothers and sisters may also be affected or may be carriers, and parents are often healthy carriers. Other close relatives may also carry the variant, so the result can matter beyond just one person in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SPATA7 gene, clinicians use SPATA7 genetic testing on a blood sample, saliva, or a cheek swab. The lab reads the gene’s DNA code and compares it with the usual sequence to look for variants that may help explain inherited vision loss or clarify family risk.
When should I consider getting a genetic test?
Consider SPATA7 testing if you or your child has unexplained early vision loss, night blindness, or a family history of an inherited retinal condition affecting the light-sensing layer at the back of the eye. A test can help confirm the cause and clarify chances for other family members.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, yet how much they explain varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. It studies relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can affect how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SPATA7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so any concerns about treatment, side effects, or changes in your health are best discussed with your doctor.
History
SPATA7 entered the medical literature in the late 2000s as researchers studying inherited eye conditions searched for the genetic cause in affected families. Initially understood only through visible traits, later recognized as tied to a specific gene, SPATA7 was linked to forms of childhood retinal disease including Leber congenital amaurosis and early onset retinitis pigmentosa. From these first observations, research expanded steadily as additional families with SPATA7 variants were identified in different countries. This helped confirm that the gene was part of a shared pattern of inherited vision loss rather than an isolated finding. Over time, descriptions became more precise as genetic testing made it easier to recognize SPATA7 related disease earlier in life.